Ftse Mib
37.677,27
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.554,22
-1,07%
NASDAQ
17.316,23
-0,87%
Bitcoin
81.325,49
3,66%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Jazz Pharmaceuticals PLC (JAZZ) Jazz Pharmaceuticals PLC (JAZZ) Notizie

Jazz Pharmaceuticals PLC

JAZZ
136,06
-1,39 (-1,01%)
Ultimo aggiornamento: 18:45:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202523:01EDGAR2Form 144 - Report of proposed sale of securities
10/3/202522:36EDGAR2Form 144 - Report of proposed sale of securities
08/3/202500:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202500:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202500:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202500:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202523:14EDGAR2Form 144 - Report of proposed sale of securities
07/3/202523:04EDGAR2Form 144 - Report of proposed sale of securities
07/3/202521:15EDGAR2Form 144 - Report of proposed sale of securities
05/3/202522:17EDGAR2Form SC TO-C - Written communication relating to an issuer..
05/3/202522:15EDGAR2Form 8-K/A - Current report: [Amend]
05/3/202513:11EDGAR2Form SC TO-C - Written communication relating to an issuer..
05/3/202513:09EDGAR2Form 8-K - Current report
05/3/202513:00PRNUSJazz Pharmaceuticals to Acquire Chimerix, Further..
04/3/202502:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202502:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202501:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202501:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202501:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202501:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202523:43EDGAR2Form 144 - Report of proposed sale of securities
28/2/202502:05EDGAR2Form 144 - Report of proposed sale of securities
27/2/202523:04EDGAR2Form 144 - Report of proposed sale of securities
27/2/202522:56EDGAR2Form 144 - Report of proposed sale of securities
26/2/202513:34EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
25/2/202522:06EDGAR2Form 8-K - Current report
25/2/202522:05PRNUSJazz Pharmaceuticals Announces Full Year and Fourth Quarter..
20/2/202522:15PRNUSJazz Pharmaceuticals to Participate in TD Cowen's 45th..
11/2/202522:15PRNUSJazz Pharmaceuticals to Report 2024 Full Year and Fourth..
03/2/202523:04EDGAR2Form 144 - Report of proposed sale of securities
23/1/202500:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202500:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202500:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202500:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202500:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202513:45EDGAR2Form 8-K - Current report
17/12/202422:15PRNUSJazz Pharmaceuticals to Present at the 43rd Annual J.P...
16/12/202422:43EDGAR2Form 8-K - Current report
16/12/202422:05PRNUSJazz Pharmaceuticals Announces CEO Succession Plan
10/12/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:05PRNUSJazz Pharmaceuticals to Showcase New Real-World Evidence..
05/12/202413:45PRNUSJazz Pharmaceuticals Announces Update to National..
04/12/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:15PRNUSJazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii)..
03/12/202413:49PRNUSJazz Pharmaceuticals to Present Advancements in Solid Tumors..
02/12/202422:20EDGAR2Form 144 - Report of proposed sale of securities
21/11/202412:06EDGAR2Form 8-K - Current report
21/11/202401:19PRNUSJazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera®..
19/11/202422:05PRNUSJazz Pharmaceuticals to Participate in Citi's 2024 Global..
13/11/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 136,25 Min: 134,6175 Max: 137,08
Chiusura: 137,45

La tua Cronologia

NASDAQ
JAZZ
Jazz Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci